pancreatic cancer glutathione enhancement

pancreatic cancer glutathione enhancement Novel drug therapy kills cells by reducing levels of antioxidants Navigating the complexities of ferroptosis

Name: pancreatic cancer glutathione enhancement Novel drug therapy kills cells by reducing levels of antioxidants Navigating the complexities of ferroptosis
Brand: dearkhaled.com
SKU: 1540536494
Price: 29.36 USD
Availability: InStock
Rating: 4.4383 (27 reviews)

Navigating the complexities of ferroptosis in pancreatic ductal adenocarcinoma: roles, mechanisms and potential applications Cell Death Discovery Beyond the tumor: Enhancing pancreatic cancer therapy through glutamine metabolism and innovative drug delivery Su 2025 Journal of Cell Communication and Signaling Wiley Online Library Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment Frontiers Targeted drug delivery systems for pancreatic cancer therapy: advances, challenges, and future perspectives Role of Glutathione in Cancer: From Mechanisms to Therapies PMC Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3 GPX4 signalling Cell Death & Disease

SKU: 1540536494 · From dearkhaled.com

4.4

USD29.36 USD77.36

Pay in 4 interest-free payments of $7.34 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

doi: 10.1038/cddis.2014.569 196 FengACThomasBJPurbeyPKde MeloFMLiuXDalyAEet al

Inhibition of BCL2 family members increases the efficacy of copper chelation in BRAF(V600E)-driven melanoma

Cell lines were procured form ATCC and included HCT116 (CCL-247), Ca Ski (CRL-1550), SJSA-1 (CRL-2098), A549(CCL-185), Hep G2 (HB-8065), MCF-7 (HTB-22), LoVo (CCL-229), SW48 (CCL-231), SW480(CCL-228), AsPC-1(CRL-1682), HL-60 (CCL-240), LS123 (CCL-255), MDA-MB-361 (HTB-27), MIA PaCa-2 (CRL-1420), HeLa (CCL-2), MS571 (HTB-34), SiHa (HTB-35), NCI-H1299 (CRL-5803), and Saos-2 (HTB-85)